The use of cannabidiol (CBD) as an analgesic component

Kristian Kjær-Staal Petersen, Andrew SC Rice, Lars Arendt-Nielsen · 2023

Read The use of cannabidiol (CBD) as an analgesic component by Kristian Kjær-Staal Petersen, Andrew SC Rice, Lars Arendt-Nielsen (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10679851.txt.

Description

A peer-reviewed research article from Europe PMC (2023). research examining the efficacy and safety of cannabinoids as analgesics. It was concluded that the available evidence does not support the use of cannabinoids as analgesics on either safety or efficacy grounds.1 In particular, a meta-analysis of 36 randomised controlled clinical trials (RCTs), which included 7217 subjects, was unable to identify any clinically important analgesic effects, and identified that the current literature was of low and very-low quality.2 Since then, 16 RCTs on CBD have been published3 but these studies have been

Catalog record

CREATORKristian Kjær-Staal Petersen, Andrew SC Rice, Lars Arendt-Nielsen
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE6 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10679851

Browse the full library · About the Tower of Babel